Navigation Links
New discovery on early immune system development
Date:11/12/2013

Researchers at Lund University have shed light on how and when the immune system is formed, raising hope of better understanding various diseases in children, such as leukaemia.

The immune system is complex and a number of genetic diseases are attributed to defects in the cells that form its origins. The study from Lund and Oxford University presents unique findings on the formation of these cells.

We know that the first blood stem cells are formed in the aorta region and then travel to the liver, which is the body's major blood-forming organ during the foetal stage. In the liver, the blood stem cells produce the more mature blood cells that form our blood system. At the same time, T- and B-cells are formed, which comprise the basis of our advanced immune system. From birth, this process takes place in the bone marrow and the liver ceases to form blood cells.

Researchers have long believed that the first cells that lead to the development of our immune system, the immune-competent cells, are formed from blood stem cells in the liver while the foetus is developing. Blood stem cells can be found in the liver from day 11󈝸 in a mouse foetus, which is the equivalent of around 6 weeks' gestation in humans.

In the current study, which was performed on mice, researchers showed that these cells linked to our immune system are formed even earlier than this, in the embryo's yolk sac, i.e. before the first blood stem cells are formed. In the human embryo, the yolk sac is one of the three foetal sacs and appears in around the fifth week of pregnancy.

"The question we have posed is whether the immune system is formed in a different way in the foetus than in an adult and how early in the development of the foetus the cells that form our early immune system can be found. Knowledge of this is important because it helps us to understand how and when our immune system begins to form and what can go wrong in that process", explained Charlotta Biers, a postdoctoral fellow at Lund University.

Childhood leukaemia is one example of how important it is to understand how the immune system is formed. The first mutation on the path to childhood leukaemia has been shown to take place while the child is still in the womb.

"It is still not known in which cell or cells this first step takes place and it is therefore important for us to continue our research on how the immune system starts in humans. The aim is now to continue our investigations in humans", said Charlotta Biers. If it is possible to prove that the cells mutate at this very early stage of development, then this would increase our understanding of how childhood leukaemia occurs.

"These first cells seem to disappear in the late stages of development of the foetus. This may not happen when there is a mutation. Perhaps the defective cells instead remain alive, and further mutations occur that in turn could lead a child to develop cancer."


'/>"/>

Contact: Charlotta Böiers
Charlotta.Boiers@med.lu.se
46-709-436-812
Lund University
Source:Eurekalert

Related medicine news :

1. New Episode of Innovations Airing November 18, 2013 via Discovery Channel
2. OU natural products discovery group asks for publics help with citizen science program
3. Innovations with Ed Begley, Jr. Announces New Episode Airing November 14, 2013 via Discovery Channel
4. New discovery could dramatically reduce leishmaniasis treatment doses and side effects
5. Biosimulation Market (For Drug Discovery & Development) Worth $1.2 Billion by 2017 - New Report by MarketsandMarkets
6. Discovery could lead to anti-clotting drugs with less risk of bleeding
7. International group finds 11 new Alzheimers genes to target for drug discovery
8. Biosimulation Market (Drug Discovery & Development) Worth $1.2 Billion by 2017 - New Report by MarketsandMarkets
9. New Case Management Order in New Jersey DePuy ASR Recall Litigation Extends Discovery to June 2014, More than 650 Metal Hip Lawsuits Filed in Consolidated Proceeding
10. The Producers of the In View Series Announce Upcoming Airing on the Discovery Channel
11. Ethicon Transvaginal Mesh Lawsuits Move Forward, With Scheduling of Discovery Conferences in Federal Vaginal Mesh Litigation, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... QUEENS, N.Y (PRWEB) , ... October 13, 2017 , ... ... recently became a member of ElderCounsel, a national organization of elder law and special ... constantly changing laws and rules. It also provides a forum to network with elder ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The Visiting ... Day Market. Featuring a collection of specialty vendors and unique items from across the ... and quality-focused health and wellness services offered by the VNA. The boutique will ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: